CIK 0000874015 · Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 330336973
- Phone
- 7609319200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-10 | Monia Brett P Chief Executive Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −34,103 | 0 | ||
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option exercise 10b5-1 | +32,602 | $46.10 | $1.5M | 48,991 |
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale 10b5-1 | −21,191 | $75.50 | $1.6M | 27,800 |
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale 10b5-1 | −16,086 | $76.30 | $1.2M | 11,714 |
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option exercise 10b5-1 | +4,675 | $34.69 | $162K | 16,389 |
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −4,675 | 14,025 | ||
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −32,602 | 32,601 | ||
| 2026-03-09 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −10,148 | $75.25 | $764K | 62,211 |
| 2026-03-09 | Monia Brett P Chief Executive Officer | Option exercise 10b5-1 | +40,822 | $60.89 | $2.5M | 295,803 |
| 2026-03-09 | Monia Brett P Chief Executive Officer | Option exercise 10b5-1 | +73,529 | $60.89 | $4.5M | 369,332 |
| 2026-03-09 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −7,382 | $74.11 | $547K | 361,950 |
| 2026-03-09 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −117,604 | $75.26 | $8.9M | 244,346 |
| 2026-03-09 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −1,684 | $75.58 | $127K | 242,662 |
| 2026-03-09 | Monia Brett P Chief Executive Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −40,822 | 107,632 | ||
| 2026-03-09 | Monia Brett P Chief Executive Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −73,529 | 34,103 | ||
| 2026-03-04 | LOSCALZO JOSEPH Director | Option exercise 10b5-1 | +200 | $38.06 | $8K | 36,530 |
| 2026-03-04 | LOSCALZO JOSEPH Director | Sale 10b5-1 | −200 | $80.00 | $16K | 36,330 |
| 2026-03-04 | LOSCALZO JOSEPH Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −200 | 10,968 | ||
| 2026-03-04 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +238 | $56.78 | $14K | 4,585 |
| 2026-03-04 | Baroldi Joseph EVP, Chief Business Officer | Sale 10b5-1 | −238 | $80.00 | $19K | 4,347 |
Page 8 of 18 · 360 trades